We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biomolecule Detection Technology to Make Lab-on-a-Chip Devices Smaller, Faster

By LabMedica International staff writers
Posted on 20 Jul 2022

New research has overcome a major challenge to isolating and detecting molecules at the same time and at the same location in a microdevice. More...

The work by scientists at the University of Massachusetts Amherst (Amherst, MA, USA) demonstrates an important advance in using graphene for electrokinetic biosample processing and analysis and could allow lab-on-a-chip devices to become smaller and achieve results faster.

“For the detection of biomolecules, we usually first have to isolate them in a complex medium in a device and then send them to another device or another spot in the same device for detection,” said Jinglei Ping, an assistant professor at the Mechanical and Industrial Engineering Department, who is also affiliated with the Institute of Applied Life Sciences. “Now we can isolate them and detect them at the same microscale spot in a microfluidic device at the same time.

“No one has ever demonstrated this before,” he continued. “This is owing to our use of graphene, a nanomaterial as thin as a single carbon atom, as microelectrodes in a microfluidic device. We found that, compared to typical inert-metal microelectrodes, the electrolysis stability for graphene microelectrodes is more than 1,000 times improved, making them ideal for high-performance electrokinetic analysis.”

Also, Ping added, since monolayer graphene is transparent, “we developed a three-dimensional multi-stream microfluidic strategy to microscopically detect the isolated molecules and calibrate the detection at the same time from a direction normal to the graphene microelectrodes.”

The new approach developed in the work paves the way to the creation of lab-on-a-chip devices of maximal time and size efficiencies, Ping said. Also, the approach is not limited to analyzing biomolecules and can potentially be used to separate, detect and stimulate microorganisms such as cells and bacteria.

Related Links:
University of Massachusetts Amherst 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.